Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/1996
09/03/1996US5552438 Compounds useful for treating allergic and inflammatory diseases
09/03/1996US5552424 Isoxazolines as antiinflammatory agents
09/03/1996US5552421 Leukotriene biosynthesis inhibitors
09/03/1996US5552413 Methods for inhibiting hyperproliferation of kerntinocytes
09/03/1996US5552400 Inhibitors of protease activity
09/03/1996US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
09/03/1996US5552381 Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity
09/03/1996US5552300 T cell antigen receptor V region proteins and methods of preparation thereof
09/03/1996US5552142 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
08/1996
08/29/1996WO1996026288A1 A method for the isolation and purification of lipid cell-wall components
08/29/1996WO1996026285A2 Methods and compositions for administering gene therapy vectors
08/29/1996WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/29/1996WO1996026274A1 Antagonists of interleukin-15
08/29/1996WO1996026267A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
08/29/1996WO1996026179A1 Novel cationic lipids and the use thereof
08/29/1996WO1996025953A1 Redirection of cellular immunity by receptor chimeras
08/29/1996WO1996025945A1 ISOFORMS OF HUMAN INTERLEUKIN-1β CONVERTING ENZYME AND METHODS OF USING THE SAME
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025941A1 Modulators of regulatory proteins
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996WO1996017869A3 Interleukin-6 (il-6) antagonists
08/29/1996WO1996016675A3 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
08/29/1996CA2213484A1 Modulators of regulatory proteins
08/29/1996CA2213439A1 Methods and compositions for administering gene therapy vectors
08/29/1996CA2213428A1 A method for the isolation and purification of lipid cell-wall components
08/29/1996CA2213417A1 Novel cationic lipids and the use thereof
08/29/1996CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2211743A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996CA2211541A1 Isoforms of human interleukin-1.beta. converting enzyme and methods of using the same
08/29/1996CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728481A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728134A1 6-oxo-nucleosides useful as immunosuppressants
08/28/1996EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes
08/28/1996EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727998A1 Oxazoles for treating cytokine mediated diseases
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996EP0727993A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds
08/28/1996EP0727990A1 Compounds, compositions and treatment of allergies and inflammation
08/28/1996EP0621862B1 Organic salts of n, n'-diacetyl cystine
08/28/1996EP0582711B1 Ketotricyclo(5.2.1.0)decane derivates
08/28/1996EP0397697B1 Quinoline derivatives as antagonists of leukotriene d 4?
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1032648C Process for preparation of platelet activating factor antagonist
08/28/1996CA2170222A1 Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections
08/27/1996US5550162 N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide derivatives, their preparation and their therapeutic use
08/27/1996US5550152 Antiinflammatory agents
08/27/1996US5550143 Heterocyclic compounds
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/27/1996CA1338561C Aromatic esters and thioesters; process for preparing the same and their use in human or animal medecine and in cosmetics
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression
08/22/1996WO1996025157A1 Il-8 receptor antagonists
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726913A1 Cytokines from natural killer or t cells
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726897A1 Process for the preparation of n-4- (substituted phenyl)alkylthienyl]-, and n-4- (substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726772A1 A method for sensitization of cancer cells for killer cell mediated lysis
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/21/1996EP0660723B1 Vp6 encapsulated drug delivery
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0593440B1 Use of honey as vaccine
08/21/1996EP0589949B1 New peptides (didemnins), their preparation and their use
08/21/1996EP0540614B1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives
08/21/1996EP0474672B1 New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129440A Phenoxyphenyl cyclopentenyl hydroxyureas
1 ... 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 ... 1172